Features
AI-enabled identification of antimicrobial peptides
Selective targeting against pathogenic bacteria
Minimal microbiome disruption
Topical therapeutic for Bacterial Vaginosis
Proprietary validation platform
Inspired by evolutionary milk proteins
Early-stage R&D for infectious diseases
Collaboration with UC Davis Foods For Health Institute
Focus on reducing antibiotic resistance
Preclinical-stage pipeline
Autonomous hypothesis generation with agentic AI
Multimodal patient data integration (spatial, multi-omics, clinical)
Clinical trial design and patient stratification
Patient and population analytics
Early portfolio decision insights
Patient validation through wet lab infrastructure
Target ID engine distinguishing novel from rediscovery
Collaborative network of 30+ academic centers
Multi-year partnership with Sanofi for custom AI agents
NVIDIA collaboration for biological benchmark testing
Narrows search space in aging research
K Pro connected to front-end user feedback
Support for antibody-drug conjugate development via spatial biology
